Average Co-Inventor Count = 4.29
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (6 from 1,537 patents)
6 patents:
1. 11911388 - Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
2. 10092571 - Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
3. 10034877 - Treatment for diabetes in patients inappropriate for metformin therapy
4. 9486526 - Treatment for diabetes in patients inappropriate for metformin therapy
5. 9457029 - Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
6. 8853156 - Treatment for diabetes in patients inappropriate for metformin therapy